Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave, Timothy A. Troppoli, Andreas B. Wulff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 259

Showing 1-25 of 259 citing articles:

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz, Stephen Ross, Snehal Bhatt, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 953-953
Open Access | Times Cited: 414
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao, Clara Liao, Ian Gregg, et al.
Neuron (2021) Vol. 109, Iss. 16, pp. 2535-2544.e4
Open Access | Times Cited: 367
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 6, pp. 1032-1041
Open Access | Times Cited: 225
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 204
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 166
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga, Bohan Zhu, Christopher A. Guevara, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109836-109836
Open Access | Times Cited: 147
The promises and perils of psychedelic pharmacology for psychiatry
Tristan McClure‐Begley, Bryan L. Roth
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 463-473
Closed Access | Times Cited: 139
Psychedelics reopen the social reward learning critical period
Romain Nardou, Edward J. Sawyer, Young Jun Song, et al.
Nature (2023) Vol. 618, Iss. 7966, pp. 790-798
Open Access | Times Cited: 138
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
S. Parker Singleton, Andrea I. Luppi, Robin Carhart‐Harris, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
Guy M. Goodwin, Megan Croal, David Feifel, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 10, pp. 1492-1499
Open Access | Times Cited: 81
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 77
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112203-112203
Open Access | Times Cited: 68
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 351-358
Open Access | Times Cited: 56
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?
Mehdi Sekssaoui, Joël Bockaert, Philippe Marin, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 4, pp. 747-756
Open Access | Times Cited: 22
Structural pharmacology and therapeutic potential of 5-methoxytryptamines
Audrey L. Warren, David Lankri, Michael J. Cunningham, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 237-246
Open Access | Times Cited: 20
Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice
Xiangting Zhao, Yingjie Du, Yishan Yao, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 489-499
Closed Access | Times Cited: 16
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Susan Ling, Felicia Ceban, Leanna M.W. Lui, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 17-30
Closed Access | Times Cited: 79
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research
David A. Bender, David J. Hellerstein
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1907-1932
Closed Access | Times Cited: 64
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 63
Synaptic Mechanisms Regulating Mood State Transitions in Depression
Puja K. Parekh, Shane B. Johnson, Conor Liston
Annual Review of Neuroscience (2022) Vol. 45, Iss. 1, pp. 581-601
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top